- Home
- CIEN vs LNTH Comparison
CIEN vs LNTH Comparison
Compare CIEN & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIEN
- LNTH
- Stock Information
- Founded
- CIEN 1992
- LNTH 1956
- Country
- CIEN United States
- LNTH United States
- Employees
- CIEN N/A
- LNTH N/A
- Industry
- CIEN Telecommunications Equipment
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CIEN Utilities
- LNTH Health Care
- Exchange
- CIEN Nasdaq
- LNTH Nasdaq
- Market Cap
- CIEN 10.2B
- LNTH 7.5B
- IPO Year
- CIEN 1997
- LNTH 2015
- Fundamental
- Price
- CIEN $81.38
- LNTH $80.42
- Analyst Decision
- CIEN Buy
- LNTH Strong Buy
- Analyst Count
- CIEN 13
- LNTH 5
- Target Price
- CIEN $82.85
- LNTH $131.20
- AVG Volume (30 Days)
- CIEN 2.9M
- LNTH 999.3K
- Earning Date
- CIEN 09-03-2025
- LNTH 07-30-2025
- Dividend Yield
- CIEN N/A
- LNTH N/A
- EPS Growth
- CIEN N/A
- LNTH N/A
- EPS
- CIEN 0.73
- LNTH 3.53
- Revenue
- CIEN $4,264,558,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- CIEN $16.34
- LNTH $4.63
- Revenue Next Year
- CIEN $9.74
- LNTH $9.35
- P/E Ratio
- CIEN $111.47
- LNTH $22.77
- Revenue Growth
- CIEN 2.86
- LNTH 12.53
- 52 Week Low
- CIEN $44.89
- LNTH $73.11
- 52 Week High
- CIEN $101.44
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- CIEN 61.06
- LNTH 48.55
- Support Level
- CIEN $78.09
- LNTH $78.41
- Resistance Level
- CIEN $83.28
- LNTH $82.50
- Average True Range (ATR)
- CIEN 2.12
- LNTH 2.17
- MACD
- CIEN 0.47
- LNTH 0.41
- Stochastic Oscillator
- CIEN 83.56
- LNTH 66.23
About CIEN Ciena Corporation
Ciena is a telecommunications equipment provider focused on optical transport technologies, with clients in a number of industries such as communication services providers, web-scale providers, cable operators, government, and large enterprises worldwide. The company provides equipment, software, and services that support transport, switching, aggregation, service delivery, and data traffic management.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.